N/A
N=80
The Role of Umbilical Cord Thickness in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus
Gestational Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT02643225 ↗Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Aug 2016
Primary outcome: Primary: The Number of Participants Who Were Diagnosed With Fetal Macrosomia (Birth Weight) — 17; 0 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult · 20+ yrs
- Sex
- Female
- Sponsor
- Ain Shams University
- Primary completion
- Oct 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Number of Participants Who Were Diagnosed With Fetal Macrosomia (Birth Weight) |
17; 0 | — |
| SECONDARY Umbilical Cordcross-sectional Area |
3.03; 2.25 | — |
| SECONDARY Prediction of Fetal Macrosomia by Measuring HbA1C in Participants |
6.6; 5.2 | — |
| SECONDARY Interventricular Septum Thickness |
0.85; 0.53 | — |
Summary
The aim of this work is the prediction of fetal macrosomia by measuring:
1. HbA1C.
2. Umbilical cord thickness.
3. Interventricular septum thickness.
Eligibility Criteria
Inclusion Criteria
- Singleton gestation.
- Gestational age over 27 weeks.
- Intact membranes.
- Normal umbilical morphology (two arteries and one vein).
- Diagnosis of gestational diabetes.
Exclusion Criteria
- The presence of fetal congenital anomalies.
- Multifetal pregnancy.
- Maternal chronic diseases (hypertension, renal disease, cardiac and pulmonary disease, etc.).
- Patients with a diagnosis such as oligohydramnios , pre-eclampsia and intrauterine growth retardation.
- Patients who used cigarettes or alcohol during pregnancy.
Data sourced from ClinicalTrials.gov (NCT02643225). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.